Update on testicular germ cell tumors

Current Opinion in Oncology

Volumn 22, Issue 3, 2010, Pages 236-241

  Mannuel, Heather D ^a,b   Hussain, Arif ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Genetic studies; Germ cell tumor; Imaging; Nonseminomatous germ cell tumor; Platinum refractory disease; Seminoma; Surveillance; Teratoma

Indexed keywords

PLATINUM DERIVATIVE;

CANCER CHEMOTHERAPY; CANCER GENETICS; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; NON SEMINOMATOUS GERMINOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TESTIS CANCER;

COMBINED MODALITY THERAPY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; TESTICULAR NEOPLASMS;

EID: 77951453700     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e3283384181     Document Type: Review

References (21)

1. Loehrer PJ, Ahlering T, Buyyounouski MK, et al. Testicular cancer. In: Pazdur R, editor. Cancer management: a multidisciplinary approach, 11th ed. Man-hasset, New York: CMP Media; 2008. pp. 425-446.
2. Bertuccio P, Malvezzi M, Chatenoud L, et al. Testicular cancer mortality in the Americas, 1980-2003. Cancer 2007; 109:776-779.
3. Shah MN, Devesa SS, Zhu K, McGlynn KA. Trends in testicular germ cell tumors by ethnic group in the United States. Int J Androl 2007; 30:206-213; discussion 213-214.
4. Slaughenhoupt B, Kadlec A, Schrepferman C. Testicular microlithiasis preceding metastatic mixed germ cell tumor-first pediatric report and recommended management of testicular microlithiasis in the pediatric population. Urology 2009; 73:1029-1031.
5. Hotaling JM, Walsh TJ. Male infertility: a risk factor for testicular cancer. Nat Rev Urol 2009; 6:550-556.
6. Velasco A, Corvalan A, Wistuba II, et al. Mismatch repair and expression in testicular cancer predicts recurrence and survival. Int J Cancer 2008; 122:1774-1777.
7. Honecker F, Wermann H, Mayer F, et al. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol 2009; 27:2129-2136.
8. Tanaka K, Okamoto S, Ishikawa Y, et al. DDX1 is required for tumorigenesis, partially through the transcriptional activation of 12p stem cell genes. Oncogene 2009; 28:2142-2151.
9. Sonne SB, Almstrup K, Dalgaard M, et al. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 2009; 69:5241-5250.
10. Korkola JE, Houldsworth J, Feldman DR, et al. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol 2009; 27:5240-5247.
11. Ferlin A, Ganz F, PengoM, et al. Association of testicular germ cell tumour with polymorphisms in estrogen receptor and steroid metabolism genes. Endo crine Relat Cancer 2010; 17:17-25.
12. Tandstad T, Dahl O, Cohn-Cedarmark G, et al. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENO-TECA management program. J Clin Oncol 2009; 27:2122-2128.
13. Westermann DH, Schefer H,Thalmann GN, etal. Long-term follow up results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage 1 nonseminomatous germ cell tumors of the testis. J Urol 2008; 179:163-166.
14. Yu H, Madison R, Setodji C, et al. Quality of surveillance for stage I testis cancer in the community. J Clin Oncol 2009; 27:4327-4332.
15. Tarin TV, Sonn G, Shinghai R. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 2009; 181:627-632.
16. Giannis M, Aristotelis B, Vassiliki K, et al. Cisplatin-based chemotherapy for advanced seminoma: report of 52 cases treated in two institutions. J Cancer Res Clin Oncol 2009; 135:1495-1500.
17. Oechsle K, Bokemeyer C, Honecker F. Lenalinomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors. J Cancer Res Clin Oncol 2010; 136:165-167.
18. Nicolai N, Necchi A, Gianni L, et al. Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumors. BJU International 2009; 104:340-346.
19. Svatek RS, Spiess PE, Sundi D, et al. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer 2009; 115:1310-1317.
20. Clevenger JA, Foster RS, Ulbright TM. Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma. Modern Pathol 2009; 22:1361-1366.
21. Guo CC, Punar M, Contreras AL, et al. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol 2009; 33:1173-1178.